Cargando…
The versatile nature of miR-9/9(*) in human cancer
miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945517/ https://www.ncbi.nlm.nih.gov/pubmed/29755694 http://dx.doi.org/10.18632/oncotarget.24889 |
_version_ | 1783322004891369472 |
---|---|
author | Nowek, Katarzyna Wiemer, Erik A.C. Jongen-Lavrencic, Mojca |
author_facet | Nowek, Katarzyna Wiemer, Erik A.C. Jongen-Lavrencic, Mojca |
author_sort | Nowek, Katarzyna |
collection | PubMed |
description | miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in the deregulation of physiological and biochemical networks in human disease. In this review, we present a comprehensive overview of the involvement of miR-9/9(*) in various human malignancies focusing on their opposing roles in supporting or suppressing tumor development and metastasis. Importantly, it is shown that the capacity of miR-9/9(*) to impact tumor formation is independent from their influence on the metastatic potential of tumor cells. Moreover, data suggest that miR-9/9(*) may increase malignancy of one cancer cell population at the expense of another. The functional versatility of miR-9/9(*) emphasizes the complexity of studying miRNA function and the importance to perform functional studies of both miRNA strands in a relevant cellular context. The possible application of miR-9/9(*) as targets for miRNA-based therapies is discussed, emphasizing the need to obtain a better understanding of the functional properties of these miRNAs and to develop safe delivery methods to target specific cell populations. |
format | Online Article Text |
id | pubmed-5945517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59455172018-05-13 The versatile nature of miR-9/9(*) in human cancer Nowek, Katarzyna Wiemer, Erik A.C. Jongen-Lavrencic, Mojca Oncotarget Review miR-9 and miR-9(*) (miR-9/9(*)) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9(*) in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in the deregulation of physiological and biochemical networks in human disease. In this review, we present a comprehensive overview of the involvement of miR-9/9(*) in various human malignancies focusing on their opposing roles in supporting or suppressing tumor development and metastasis. Importantly, it is shown that the capacity of miR-9/9(*) to impact tumor formation is independent from their influence on the metastatic potential of tumor cells. Moreover, data suggest that miR-9/9(*) may increase malignancy of one cancer cell population at the expense of another. The functional versatility of miR-9/9(*) emphasizes the complexity of studying miRNA function and the importance to perform functional studies of both miRNA strands in a relevant cellular context. The possible application of miR-9/9(*) as targets for miRNA-based therapies is discussed, emphasizing the need to obtain a better understanding of the functional properties of these miRNAs and to develop safe delivery methods to target specific cell populations. Impact Journals LLC 2018-04-17 /pmc/articles/PMC5945517/ /pubmed/29755694 http://dx.doi.org/10.18632/oncotarget.24889 Text en Copyright: © 2018 Nowek et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Nowek, Katarzyna Wiemer, Erik A.C. Jongen-Lavrencic, Mojca The versatile nature of miR-9/9(*) in human cancer |
title | The versatile nature of miR-9/9(*) in human cancer |
title_full | The versatile nature of miR-9/9(*) in human cancer |
title_fullStr | The versatile nature of miR-9/9(*) in human cancer |
title_full_unstemmed | The versatile nature of miR-9/9(*) in human cancer |
title_short | The versatile nature of miR-9/9(*) in human cancer |
title_sort | versatile nature of mir-9/9(*) in human cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945517/ https://www.ncbi.nlm.nih.gov/pubmed/29755694 http://dx.doi.org/10.18632/oncotarget.24889 |
work_keys_str_mv | AT nowekkatarzyna theversatilenatureofmir99inhumancancer AT wiemererikac theversatilenatureofmir99inhumancancer AT jongenlavrencicmojca theversatilenatureofmir99inhumancancer AT nowekkatarzyna versatilenatureofmir99inhumancancer AT wiemererikac versatilenatureofmir99inhumancancer AT jongenlavrencicmojca versatilenatureofmir99inhumancancer |